Rossnagl S, Ghura H, Groth C, Altrock E, Jakob F, Schott S, Wimberger P, Link T, Kuhlmann JD, Stenzl A, Hennenlotter J, Todenhöfer T, Rojewski M, Bieback K, Nakchbandi IA. "A subpopulation of stromal cells controls cancer cell homing to the bone marrow". Cancer Res. 2017 Oct 24. pii: canres.3507.2016. doi: 10.1158/0008-5472.CAN-16-3507. [Epub ahead of print]

Klemis V, Ghura H, Frederico G, Wuerfel C, Bentmann A, Gretz N, Miyazaki T, Groene H-J, Nakchbandi IA. "Circulating Fibronectin Contributes to Mesangial Expansion in a Murine Model of Type I Diabetes", Kidney International 2017 Jun;91(6):1374-1385. doi: 10.1016/j.kint.2016.12.006. Epub 2017 Jan 31.

Sens C, Huck K, Pettera S, Uebel S, Wabnitz G, Moser M, Nakchbandi IA.  Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins. J Biol Chem. 2017 May 12;292(19):7745-7760. doi: 10.1074/jbc.M116.739987. Epub 2017 Mar 21.

Sens C, Altrock E, Rau K, Klemis V, von Au A, Pettera S, Uebel S, Damm T, Tiwari S, Moser M, Nakchbandi IA. "An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin", J Bone Miner Res. 2017 Jan;32(1):70-81. doi: 10.1002/jbmr.2916.


Rossnagl S, Altrock E, Sens C, Kraft S, Rau K, Milsom MD, Giese T, Samstag Y, Nakchbandi IA. "EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer", PLoS Biol. 2016 Sep 21;14(9):e1002562. doi: 10.1371/journal.pbio.1002562.

Kraft S, Klemis V, Sens C, Lenhard T, Jacobi C, Samstag Y, Wabnitz G, Kirschfink M, Wallich R, Hänsch GM, Nakchbandi IA. "Identification and characterization of a unique role for EDB fibronectin in phagocytosis", J Mol Med (Berl). 2016 May;94(5):567-81. doi: 10.1007/s00109-015-1373-0.


Altrock E, Sens C, Würfel C, Vasel M, Kawelke N, Dooley S, Sottile J, Nakchbandi IA. "Inhibition of Fibronectin Deposition Improves Experimental Liver Fibrosis". J Hepatol. 2015, Mar;62(3):625-33. doi: 10.1016/j.jhep.2014.06.010. Epub 2014 Jun 16.


Nakchbandi IA. "Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications". World J Gastroenterol. 2014, Jul 28;20(28):9427-38. doi: 10.3748/wjg.v20.i28.9427. Review.

Riplinger SM, Wabnitz GH, Kirchgessner H, Jahraus B, Lasitschka F, Schulte B, van der Pluijm G, van der Horst G, Hämmerling GJ, Nakchbandi I, Samstag Y. "Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation". Mol Cancer. 2014 Jan 18;13:10. doi: 10.1186/1476-4598-13-10.

Rossnagl S, von Au A, Vasel M, Cecchini MG, Nakchbandi IA. "Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer". PLoS One. 2014 Apr 16;9(4):e94922. doi:10.1371/journal.pone.0094922. eCollection 2014.

Vasel M, Bersch C, Feick P, Kirschfink M, Nakchbandi IA. "Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C", Clin Immunol. 2014 Feb;150(2):149-56. doi: 10.1016/j.clim.2013.11.014. Epub 2013 Dec 5.


von Au A, Vasel M, Kraft S, Hackl N, Sens C, Marx A, Stroebel P, Hennelotter J, Todenhöfer T, Stenzl A, Schott S, Sinn HP, Wetterwald A, Bermejo JL, Cecchini MG, Nakchbandi IA. "Circulating fibronectin controls tumor growth". Neoplasia. 2013 Aug;15(8):925-38.


Kawelke N, Vasel M, Sens C, Nakchbandi IA. "Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β", PLoS ONE 2011;6(11):e28181.

Brunner M, Millon-Fremillon A, Chevalier G, Nakchbandi IA, Mosher D, Block M, Albiges-Rizo C, Bouvard D. "Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin deposition", J Cell Biol 2011 Jul 25;194(2):307-22.

Schmidt S, Nakchbandi I, Ruppert R, Kawelke N, Hess MW, Pfaller K, Jurdic P, Fässler R, Moser M. "Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption", J Cell Biol 2011 Mar 7;192(5):883-97.

Nakchbandi IA. "Commentary on Grey et al. (2011): does methadone maintenance therapy adversely affect bone mass?". Addiction. 2011 Feb;106(2):355-6.


Gramoun A, Azizi N, Sodek J, Heersche JN, Nakchbandi I, Manolson MF. “Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways”. J Cell Biochem. 2010 Nov 1;111(4):1020-34.

Bentmann A, Kawelke N, Moss D, Zentgraf H, Bala Y, Berger I, Gasser JA, Nakchbandi IA, “Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function”, J Bone Miner Res. 2010 Apr;25(4):706-15.

Hackl NJ, Bersch C, Feick P, Antoni C, Franke A, Singer MV, Nakchbandi IA. “Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C”, Scand J Gastroenterol. 2010 Mar;45(3):349-56.


Nakchbandi IA, van der Merwe SW, “Current understanding of osteoporosis associated with liver disease”, Nat Clin Rev Gastroenterol Hepatol. 2009 Nov;6(11):660-70.


Nakchbandi W, Müller H, Singer MV, Löhr JM, Nakchbandi IA, “Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma”, J Gastrointestin Liver Dis. 2008 Sep;17(3):285-90.

Mörmann M, Thederana M, Nackchbandi I, Giese T, Wagner C, Hänsch GM, “Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption”, Mol Immunol. 2008 Jul;45(12):3330-7.

Phillips JA, Almeida E, Hill EL, Aguirre JI, Rivera MF, Nachbandi I, Wronski TJ, van der Meulen M, Globus RK, “Role for beta1 integrins in cortical osteocytes during acute musculoskeletal disuse”, Matrix Biol. 2008 Sep;27(7):609-18.

Nakchbandi I, Loehr M, “Coagulation, anticoagulation and pancreatic carcinoma”, Nat Clin Pract Gastroenterol Hepatol. 2008 Aug;5(8):445-55.

Kawelke N, Bentmann A, Hackl N, Hager H-D, Feick P, Geursen A, Singer MV, Nakchbandi IA, “Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation”, J Bone Miner Res. 2008 Aug;23(8):1278-86.

Nakchbandi IA, Lang R, Kinder B, Insogna KL, “The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism”, J Clin Endocrinol Metab. 2008 Mar;93(3):967-73.


Aszodi A, Legate KR, Nakchbandi I, Fassler R, “What mouse mutants teach us about extracellular matrix function”, Annu Rev Cell Dev Biol. 2006 Nov 10; 22:591-621.

Nakchbandi W, Müller H, Singer MV, Löhr M, Nakchbandi IA, “The effects of low dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma”, Scand J Gastroenetrol.2006 Sep; (9): 1095-1104.


Franke A, Nakchbandi IA, Schneider A, Harder H, Singer MV, “The effect of ethanol and alcoholic beverages on gastric emptying of solid meals in humans”, Alcohol Alcohol. 2005 May-Jun;40(3):187-93. Epub 2005 Feb 7.


O. Chatterjee & I.A. Nakchbandi, W.M. Philbrick, B.E. Dreyer, J.P. Zhang, L.K. Kaczmarek, M. L. Brines, A.E Broadus, “Endogenous parathyroid hormone-related protein functions as a neuroprotective agent”, Brain Res 2002: 930(1-2), 58-66.

K. Insogna, M.-A. Mitnick, J. Pascarella, I.A. Nakchbandi, A. Grey, U. Masiukiewicz, “Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women“, J Bone Miner Res 2002 Nov;17 Suppl 2:N108-16.

I.A. Nakchbandi, M.-A. Mitnick, R. Lang, B. Kinder, K.L. Insogna, " Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism '', J Clin Endocrinol Metab 2002 Nov;87(11):4946-51.


I.A. Nakchbandi, M. Mitnick, U.S. Masiukiewicz, B.H. Sun, and K.L. Insogna, “Interleukin-6 downregulates interleukin-11 in vitro and in vivo”, Endocrinology 2001: 142, 3850-3856.

I.A. Nakchbandi, A. Grey, U. Masiukiewicz, M.-A. Mitnick, K. Insogna, “Cytokines in Primary Hyperparathyroidism”, book chapter in The Parathyroids, Basic and Clinical Concepts, 2nd Edition. Editor: Bilezikian, J.P., Academic Press, San Diego, CA; 2001, Pages 411-422.


I.A. Nakchbandi, E.C. Weir, K.L. Insogna, W.M. Philbrick, and A.E. Broadus, “Parathyroid hormone-related protein induces spontaneous osteoclast formation via a paracrine cascade”, Proc. Natl. Acad. Sci. (USA), 2000: 97, 7296-7300.

I.A. Nakchbandi, “Tooth eruption as a model for hormonal action in development”, book chapter in Recent Research Developments in Endocrinology. Editor: Pandalai, S.G., Transworld Research Network, Trivandarum, India; 2000; Volume 1, Part 1, Pages 307-312.


I.A. Nakchbandi , J. Wirth, and S.E. Inzucchi, “Normal Pulmonary Hemodynamics Restored by Treatment of Graves’ Hyperthyroidism in a Woman with Pulmonary Hypertension”, Chest 1999, 116(5):1483-1485.
U.S. Masiukiewicz, I.A. Nakchbandi, and S.E. Inzucchi, “ Two Cases of Papillary Thyroid Carcinoma Metastatic to the Pituitary Gland”, Thyroid 1999, 9(10):1023-1027.


W.M. Philbrick, B.E. Dreyer, I.A. Nakchbandi, and A.C. Karaplis, “Parathyroid Hormone-related Protein is Required for Tooth Eruption”, Proc. Natl. Acad. Sci. (USA) 1998, 95:11846-11851.

I.A. Nakchbandi, J.C. Longenecker, M.A. Ricksecker, R.A.Latta, C. Healton, and D.G. Smith, “A decision analysis of mandatory compared with voluntary HIV testing in pregnant women”, Annals of Internal Medicine 1998;128:760-767.


I.A. Nakchbandi and J.H. Day, “Primary Cardiac Lymphoma Presenting with Gastrointestinal Symptoms”, Southern Medical Journal 1997; 90(5): 539-543.

Go to Editor View
loading content